- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (155)
- Timeline of Article Publication (4)
- Authors Evaluation (5)
- Article Quality Tracking (0)
- Reference Citation Analysis (4)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2108)
All Articles published online
|
Publishing Process of This Article
|
May 27, 2025 (publication date) through Sep 16, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shetty S, Suvarna R, Ambrose Fistus V, Modi S, Pappachan JM. Cardiovascular implications of metabolic dysfunction-associated fatty liver disease and type 2 diabetes mellitus: A meta-analysis. World J Hepatol 2025; 17(5): 105706 [PMID: 40501478 DOI: 10.4254/wjh.v17.i5.105706] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i5/105706.htm |
| Number | Citing Articles |
| 1 |
Abul Bashar Mohammad Kamrul-Hasan, Sanja Borozan, Sweekruti Jena, Lakshmi Nagendra, Deep Dutta, Saptarshi Bhattacharya, Md Saiful Islam, Joseph M Pappachan. Safety and efficacy of efruxifermin in metabolic dysfunction-associated steatohepatitis: A systematic review. World Journal of Gastrointestinal Pharmacology and Therapeutics 2025; 16(3): 110709 doi: 10.4292/wjgpt.v16.i3.110709
Abstract(37) |
Core Tip(34) |
Full Article(HTML)(285)
|
Full Article with Cover (PDF)-819K(16)
|
Audio-625K(3)
|
Peer-Review Report-261K(14)
|
Answering Reviewers-204K(12)
|
Supplementary Material-571K(11)
|
Full Article (PDF)-567K(24)
|
Full Article (XML)-161K(14)
|
Times Cited (0)
|
Total Visits (1856)
|
Open
|
| 2 |
Amedeo Lonardo, Ralf Weiskirchen. PPARs in molecular pathogenesis and drug treatment of type 2 diabetes-related MASLD. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100590
|